Mesoblast Ltd Announces New Equity Issue
Ticker: MEOBF · Form: 6-K · Filed: Nov 13, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Nov 13, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-issue, filing, company-announcement
TL;DR
MESO just dropped a new equity issue filing, might be raising cash.
AI Summary
On November 12, 2024, Mesoblast Limited announced a new issue of equity securities, filing a notification of issue with the Australian Securities Exchange. The company, incorporated in Australia, is headquartered in Melbourne and its CEO is Silviu Itescu.
Why It Matters
This filing indicates Mesoblast is raising capital or restructuring its equity, which could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — New equity issuances can dilute existing shareholders or signal financial needs, requiring careful investor consideration.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- November 12, 2024 (date) — Filing date of new issue announcement
- Australian Securities Exchange (company) — Exchange where filing was made
FAQ
What type of equity securities were issued by Mesoblast Limited?
The filing states a 'new issue announcement, notification of issue, conversion or payment up of equity securities' was made, but does not specify the exact type of securities in this excerpt.
When was the new issue announcement filed with the Australian Securities Exchange?
The announcement was filed on November 12, 2024.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Where is Mesoblast Limited's principal executive office located?
The principal executive offices are located at Level 38, 55 Collins Street, Melbourne, 3000, Australia.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited files annual reports under Form 20-F.
Filing Stats: 224 words · 1 min read · ~1 pages · Grade level 18.8 · Accepted 2024-11-12 19:08:24
Filing Documents
- a2024-11x14appendix3g.htm (6-K) — 20KB
- exhibit991.htm (EX-99.1) — 8KB
- exhibit991001.jpg (GRAPHIC) — 78KB
- exhibit991002.jpg (GRAPHIC) — 58KB
- exhibit991003.jpg (GRAPHIC) — 73KB
- exhibit991004.jpg (GRAPHIC) — 90KB
- exhibit991005.jpg (GRAPHIC) — 128KB
- exhibit991006.jpg (GRAPHIC) — 97KB
- 0001345099-24-000076.txt ( ) — 750KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Niva Sivakumar Niva Sivakumar Company Secretary Dated November 14, 2024 INDEX TO EXHIBITS Item 99.1 Appendix 3G of Mesoblast Ltd, dated November 12, 2024.